G d’Ancona

Guy's Hospital — United Kingdom

Medicine · Health Sciences

19h-index1.3kcitations131works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(62), Eosinophilic Esophagitis(20), Inhalation and Respiratory Drug Delivery(18), Chronic Obstructive Pulmonary Disease (COPD) Research(12), Respiratory and Cough-Related Research(12)

Publications131 total

P7 Sustainable care: what people with COPD are offered a lower carbon inhaler device and who is more likely to succeed in switching?
2025
M29 The effectiveness of benralizumab in the management of chronic eosinophilic pneumonia
2025
M24 The prevalence of psychological symptoms in severe and difficult asthma
2025
Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe Asthma
The Journal of Allergy and Clinical Immunology In Practice·2025
Targeted self-directed learning can support clinicians to improve patient adherence to inhaled corticosteroid therapy in asthma
BMJ Open Respiratory Research·2025Open Access
The prevalence and impact of co-morbid psychological symptoms in severe asthma
2025
The Impact of Inhaled Corticosteroid Use on the Effectiveness of Tezepelumab in Severe Asthma
2025
A 5-year retrospective review of young patients with severe asthma transitioning to a dedicated adolescent clinic
2025
Clinical characteristics associated with frequent asthma exacerbations whilst on treatment with tezepelumab
2025
What people with COPD are offered a switch to lower carbon inhaler device and who is more likely to succeed in switching?
2025
Characterizing exacerbations in severe asthma patients treated with tezepelumab
2025
Acute use of nintedanib for rapidly progressive pulmonary fibrosis: experience of inpatient use at a tertiary interstitial lung disease service
2025
Tezepelumab in Patients With Eosinophilic Granulomatosis With Polyangiitis After Suboptimal Response to Anti-IL-5/5R Therapy
CHEST Journal·2025· 3 cited
Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma
Allergy·2025· 18 citedOpen Access
Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe Asthma
The Journal of Allergy and Clinical Immunology In Practice·2025· 1 citedOpen Access
Assessment of medication adherence
European Respiratory Society eBooks·2025
P44 Sustainable care: what are the characteristics of people with asthma who successfully switch to low carbon inhaler devices?
2024
P42 Sustainable care: which people with asthma are offered a lower carbon inhaler device by clinicians and what stops them wanting to switch?
2024
S103 Clinical effectiveness of tezepelumab on upper and lower respiratory symptoms in patients with asthma and co-morbid nasal polyposis
2024
M2 Real world effectiveness of tezepelumab for adolescents and young adults with severe asthma
2024
page 1 of 7Next →

Frequent Co-authors

Cris Roxas(23), David J. Jackson(21), Jaideep Dhariwal(20), Brian D. Kent(20), Mariana Fernandes(17), Linda K. Green(17), Alexandra M. Nanzer(15), Louise Thomson(14), Joanne Kavanagh(12), A Hearn(12), J Kavanagh(6), BD Kent(5), Panagis Drakatos(4), Guy Leschziner(4), Alexandra M. Nanzer(4), J Lam(4), Jessica Gates(4), Seán Higgins(3), Ivana Rosenzweig(3), Elaine Lyons(3)